FdaApplication

BLA 125428

Back to search

Identifiers

Properties

PropertyValue
applicant_nameDynavax Technologies Corporation
application_typeBLA
approval_date2017-11-09

Products (1)

ProductActive ingredientStrengthDosage form
HEPLISAV-B—20UG/.5MLInjection

1 product